Dr. Heckman’s clinical research uses a biopsychosocial approach to understand and treat addictive behaviors, and focuses on cigarette smoking. Specific interests include: 1) identification of biobehavioral mechanisms that maintain dependence (e.g., self-control depletion, cessation fatigue, craving, affect, pain); 2) development of relapse prevention interventions (e.g., just-in-time adaptive interventions, mHealth); and 3) use of behavioral economics to inform tobacco control policies (e.g., demand for alternative nicotine/tobacco products). He uses a variety of methodologies, including: survey development, meta-analysis, laboratory studies, randomized controlled trials, and population-based cessation surveillance. He is currently working to develop and test the first just-in-time adaptive interventions that can automatically detect triggers for smoking relapse and respond with real-time treatment delivery, which will be accomplished by transforming smartphones into context-aware healthcare delivery systems. His research has been funded by the National Institute of Drug Abuse (NIDA) since 2012. When taking a break from research, Dr. Heckman is likely to be spending time with friends/family, traveling, cooking, or enjoying nature.